Literature DB >> 8157476

A phase II trial of gallium nitrate in advanced previously untreated colorectal cancer.

V A Canfield1, A P Lyss.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8157476     DOI: 10.1007/bf00874434

Source DB:  PubMed          Journal:  Invest New Drugs        ISSN: 0167-6997            Impact factor:   3.850


× No keyword cloud information.
  5 in total

1.  Phase I clinical studies with gallium nitrate.

Authors:  A Y Bedikian; M Valdivieso; G P Bodey; M A Burgess; R S Benjamin; S Hall; E J Freireich
Journal:  Cancer Treat Rep       Date:  1978-10

Review 2.  Gallium nitrate: the second metal with clinical activity.

Authors:  B J Foster; K Clagett-Carr; D Hoth; B Leyland-Jones
Journal:  Cancer Treat Rep       Date:  1986-11

3.  Gallium nitrate in malignant lymphoma: a Southwest Oncology Group study.

Authors:  J K Weick; R L Stephens; L H Baker; S E Jones
Journal:  Cancer Treat Rep       Date:  1983-09

4.  Phase I-II clinical trial of gallium nitrate (NSC-15200).

Authors:  M K Samson; R J Fraile; L H Baker; R O'Bryan
Journal:  Cancer Clin Trials       Date:  1980

5.  Treatment of patients with advanced malignant lymphoma using gallium nitrate administered as a seven-day continuous infusion.

Authors:  R P Warrell; C J Coonley; D J Straus; C W Young
Journal:  Cancer       Date:  1983-06-01       Impact factor: 6.860

  5 in total
  1 in total

Review 1.  Clinical pharmacology and clinical trials of ribonucleotide reductase inhibitors: is it a viable cancer therapy?

Authors:  Mukundan Baskar Mannargudi; Subrata Deb
Journal:  J Cancer Res Clin Oncol       Date:  2017-06-17       Impact factor: 4.322

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.